Our management team
Chief Executive Officer: Dr Christophe Lautrette
Christophe is Doctor of the University of Limoges (France) with a particular interest in Biology-Health. He is laureate of the thesis Prize in 2003. In addition to his research activities, Christophe has also held teaching positions at the University of Limoges. Christophe began to develop the technology supporting the Oncogramme project at the University of Limoges in the EA 3842, Faculty of Medicine of Limoges. To complete his education, Christophe participated to several entrepreneurial training organized by the Doctoral School “Health Science Technology” and the Chamber of Commerce and Industry of Limoges. Then he integrated the Limousin business incubator for the non-technical aspects. He especially participated to “Challenge” of HEC – Paris (L’École des hautes études commerciales de Paris, class 21) for training in all aspects of the creation of innovative companies (business, management, strategy, intellectual property, entrepreneurs network). He has continued his research work with more 10 scientific publications and patents dedicated to cellular homeostatis. Christophe is holding the position of President Oncomedics SAS since its inception in August 2006.
Chief Scientific Officer: Dr Stéphanie Giraud
Stéphanie is Doctor of the University of Limoges in Biology and Health. She also has experience of teaching at the University level (ATER) and also of clinical research (ARC) at the University Hospital of Limoges. Stéphanie has actively participated to the creation of Oncomedics with Christophe. She is involved since 2004 mainly on its technical aspects. Her research is oriented oncology and the study of the mechanisms of cell death and proliferation. Stéphanie now controls all the technical research and development of Oncomedics as Chief Scientific Officer of Oncomedics since its inception in August 2006.
Production Director: Dr Christophe Morand du Puch
Christophe holds a Bachelor of Science from the College of Charleston (South Carolina, USA) and is also Doctor of the University Joseph Fourier-Grenoble I in Chemistry-Biology. Christophe worked at previous positions on several programs of both academic research (College of Charleston, Charleston, INSERM, Paris, Atomic Energy Commission, Grenoble) and industrial research (Atheris laboratories, Geneva). His activities have enabled him to acquire a broad spectrum of expertise in cell biology, molecular biology, and biochemistry. His thesis focused on the study of the mechanisms of formation of chemical DNA damage and repair of these lesions by cells in close contact with the therapeutic approaches of certain cancers. Christophe joined Oncomedics as project manager in January 2011, in charge of the hospital clinical research protocol on the method of Oncogramme for colon cancer.